SC 13D

Company

GALECTIN THERAPEUTICS INC

Filed

October 31, 2007

Accession Number

0001104659-07-078201

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →